Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous calcium gluconate prophylaxis after total thyroidectomy in toxic multinodular goiter
IRCT20240503061640N1Phase 3Completed
- Sponsor
- Combined Military Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of calcium gluconate in hypocalcemia (2 arms), sponsored by Combined Military Hospital. Primary endpoints: Postoperative calcium level and Postoperative hypocalcemia duration. Started Oct 2023; status: completed.
02
Drugs
calcium gluconate
03
Conditions
hypocalcemia
Beyond the preview
Go deeper on IRCT20240503061640N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240503061640N1.